Source: International Congress 2018 – Basic pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Matschiner (Boston, United States of America), S. Huang (Geneva, Switzerland), S. Constant (Geneva, Switzerland), B. Rattenstetter (Boston, United States of America), H. Gille (Niederzier, Germany), A. Hohlbaum (Ghent, Belgium), B. Koller (Chapell Hill, United States of America), D. Keeling (Gothenburg, Sweden), M. Fitzgerald (Boston, United States of America). The Discovery and Development of AZD1402/PRS-060, an Inhaled, Potent and Selective Antagonist of the IL-4 Receptor Alpha. 1047

Member's Comments

No comment yet.

Related content which might interest you: TLR7 Expression Reveals Novel Bronchodilating Mechanism of Imidazoquinoline Agonists Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Effects of Inhaled Long Acting Muscarinic Antagonist (LAMA) on Lung Functions in Adult Stable Bronchiectasis Source: International Congress 2018 – COPD management Year: 2018 Aerosolized TLR7 Imidazoquinoline Agonist Bronchodilates In Vivo Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 Broader Impact of IL-4Ra Blockade Than IL-5 Blockade on Type 2 Inflammation Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Modulation of Transient Receptor Potential Vanilloid-1 (TRPV1) response by inhaled prostaglandin-E2 and bradykinin Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018 Late Breaking Abstract - Activation of a murine skeletal muscle M3 muscarinic Designer Receptor Exclusively Activated by Designer Drug (DREADD) has cardiopulmonary consequences Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019 Endogenous Anti-Inflammatory Mechanisms and the Role of Lipoxins Source: Research Seminar 2007 - Severe Asthma Year: 2007 Late Breaking Abstract - ACE2 Overexpression Modulates Nicotine Receptors In Cell Type Specific Manner: Possible Relevance In Covid-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021 The Effect of Cordycepin and Simvastatin on Cigarettes Smoke Extract Induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 RAGE Partially Mediates Cigarettes Smoke Extract induced Cytokine and Chemokine Production in Human Bronchial Epithelial Cells Source: International Congress 2018 – COPD: immune regulation and therapeutic targets Year: 2018 Erythromycin Reverses Nets-induced Corticosteroid Insensitivity By Inhibition Of The Pi3kd/akt Pathway Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies Year: 2020 Comparative Efficacy of Long-Acting Muscarinic Antagonists in COPD: Real Life Study Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Clinical Evidence for Targeted Strategies in Asthma with Type 2 Inflammation: Single and Dual Inhibition Source: International Congress 2017 – Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics Year: 2017 Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020 Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Late Breaking Abstract - Chronic Hypoxia Promotes Pulmonary Venous Smooth Muscle Cells Proliferation by Upregulating Calcium Sensing Receptor Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 LSC - 2017 - Proteasomal Activator 200 (PA200) Regulates Cellular Proliferation: A Putative Role For IPF And Lung Cancer Pathogenesis Source: International Congress 2017 – New insights into pathogenesis of lung disease  Year: 2017 Mast Cell Tryptase Enhances Wound-Healing via Protease-Activated Receptor-2 Dependent Migration in Human Bronchial Epithelial Cells Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Association of the Monocyte Chemoattractant Protein 1 and Chemokine Receptor 2 Genetic Polymorphisms with Non-small Cell Lung Cancer in Taiwan Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017